LeonaBio公司

簡介

本頁面提供了有關 Mark James Litton 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Mark James Litton已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:LONA / LeonaBio, Inc. PRESIDENT and CEO, Director 57,926
US:ALPN / Alpine Immune Sciences, Inc. See Remarks 75,000
US:ALDR / Alder BioPharmaceuticals, Inc. Chief Business Officer 0
如何解讀這些圖表

以下圖表顯示了在Mark James Litton進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

LONA / LeonaBio, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 LONA / LeonaBio, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

LONA / LeonaBio, Inc. Insider Trades
LONA / LeonaBio, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 LONA / LeonaBio, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2026-03-04 LONA Litton Mark James 5,156 5.3700 5,156 5.3700 27,688 2 5.3000 -360 -1.30
2026-01-02 ATHA Litton Mark James 2,586 6.8800 2,586 6.8800 17,792
2025-07-01 ATHA Litton Mark James 25,123 0.2935 2,512 2.9350 7,374
2025-01-02 ATHA Litton Mark James 25,107 0.5619 2,511 5.6190 14,108
2024-09-05 ATHA Litton Mark James 5,032 0.5660 503 5.6600 2,848
2024-01-05 ATHA Litton Mark James 4,820 2.9100 482 29.1000 14,026
2024-01-05 ATHA Litton Mark James 4,820 2.9100 482 29.1000 14,026
2022-06-23 ATHA Litton Mark James 7,960 2.6900 796 26.9000 21,412

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

LONA / LeonaBio, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Mark James Litton 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-03-05 2026-03-04 4 LONA LeonaBio, Inc.
Common Stock
S - Sale -5,156 57,926 -8.17 5.37 -27,688 311,063
2026-03-05 2026-03-03 4 LONA LeonaBio, Inc.
Common Stock
M - Exercise 22,254 63,082 54.51
2026-01-05 2026-01-02 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -2,586 40,828 -5.96 6.88 -17,792 280,897
2026-01-05 2025-12-31 4 ATHA Athira Pharma, Inc.
Common Stock
M - Exercise 10,834 43,414 33.25
2025-07-02 2025-07-01 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -25,123 325,802 -7.16 0.29 -7,374 95,623
2025-07-02 2025-06-30 4 ATHA Athira Pharma, Inc.
Common Stock
M - Exercise 108,334 350,925 44.66
2025-01-03 2025-01-02 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -25,107 242,591 -9.38 0.56 -14,108 136,312
2025-01-03 2024-12-31 4 ATHA Athira Pharma, Inc.
Common Stock
M - Exercise 108,333 267,698 67.98
2024-09-05 2024-09-05 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -5,032 159,365 -3.06 0.57 -2,848 90,201
2024-09-05 2024-09-03 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 164,397 13.85
2024-02-16 2024-01-05 4/A ATHA Athira Pharma, Inc.
Common Stock
S - Sale -4,820 144,397 -3.23 2.91 -14,026 420,195
2024-02-16 2024-01-04 4/A ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 149,217 15.48
2024-01-08 2024-01-05 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -4,820 144,397 -3.23 2.91 -14,026 420,195
2024-01-08 2024-01-04 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 149,217 15.48
2023-01-31 2022-11-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 662 129,217 0.51 2.74 1,814 354,055
2022-06-24 2022-06-23 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -7,960 128,555 -5.83 2.69 -21,412 345,813
2022-06-24 2022-06-22 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 136,515 17.17
2022-06-24 2022-05-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 757 116,515 0.65 7.06 5,344 822,596
2022-01-31 2022-01-27 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy)
A - Award 400,000 400,000
2022-01-31 2021-11-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 885 115,758 0.77 12.51 11,071 1,448,133
2021-08-19 2021-08-17 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy)
M - Exercise -50,440 100,880 -33.33
2021-08-19 2021-08-17 4 ATHA Athira Pharma, Inc.
Common Stock
M - Exercise 50,440 114,873 78.28 1.35 68,094 155,079
2021-08-19 2021-05-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 867 64,433 1.36 14.45 12,528 931,057
2021-02-22 2021-02-18 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy)
A - Award 85,000 85,000
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B-1 Preferred Stock
C - Conversion -6,563 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B-1 Preferred Stock
C - Conversion -6,563 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B-1 Preferred Stock
C - Conversion -6,563 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B Preferred Stock
C - Conversion -13,126 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 6,563 6,563
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 6,563 6,563
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 6,563 6,563
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 13,126 63,566 26.02
2020-09-17 3 ATHA Athira Pharma, Inc.
Common Stock
50,440
2019-02-08 2019-02-06 4 ALPN ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
A - Award 75,000 75,000
2019-02-08 2019-02-06 4 ALPN ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2018-08-08 2018-08-06 4 ALPN ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
A - Award 150,000 150,000
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -22,727 0 -100.00
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -4,474 102,189 -4.19 18.24 -81,587 1,863,498
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -18,253 106,663 -14.61 17.74 -323,825 1,892,298
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 22,727 124,916 22.24 0.99 22,500 123,667
2018-02-21 2018-02-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 75,000 75,000
2017-11-15 2017-11-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -16,519 0 -100.00
2017-11-15 2017-11-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -16,519 99,932 -14.19 10.80 -178,486 1,079,755
2017-11-15 2017-11-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 16,519 116,451 16.53 1.65 27,256 192,144
2017-10-18 2017-10-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -16,520 16,519 -50.00
2017-10-18 2017-10-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -16,520 99,932 -14.19 12.33 -203,703 1,232,232
2017-10-18 2017-10-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 16,520 116,452 16.53 1.65 27,258 192,146
2017-01-31 2017-01-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 60,000 60,000
2017-01-20 2017-01-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1,498 33,039 -4.34
2017-01-20 2017-01-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,498 99,932 -1.48 23.10 -34,599 2,308,089
2017-01-20 2017-01-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 1,498 101,430 1.50 1.65 2,472 167,360
2017-01-09 2017-01-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -500 34,537 -1.43
2017-01-09 2017-01-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -500 99,932 -0.50 23.00 -11,500 2,298,436
2017-01-09 2017-01-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X -500 100,432 -0.50 1.65 -825 165,713
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1,326 35,037 -3.65
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -5,474 0 -100.00
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -6,800 99,932 -6.37 23.02 -156,520 2,300,195
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 1,326 106,732 1.26 1.65 2,188 176,108
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 5,474 105,406 5.48 1.26 6,925 133,339
2017-01-09 2017-01-05 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -2,216 5,474 -28.82
2017-01-09 2017-01-05 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,216 99,932 -2.17 23.00 -50,972 2,298,626
2017-01-09 2017-01-05 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 2,216 102,148 2.22 1.26 2,803 129,217
2016-10-19 2016-10-17 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,000 26,000 -7.14 27.50 -55,000 715,000
2016-10-19 2016-10-17 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,000 26,000 -7.14 27.50 -55,005 715,065
2016-10-19 2016-10-17 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,000 26,000 -7.14 27.50 -54,993 714,906
2016-07-14 2016-07-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise 25,000 0 -100.00
2016-07-14 2016-07-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 25,000 99,567 33.53 0.38 9,625 38,333
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -200 28,000 -0.71 29.64 -5,928 829,920
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,800 28,200 -6.00 28.90 -52,012 814,862
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -100 28,000 -0.36 29.60 -2,960 828,800
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -100 28,000 -0.36 29.60 -2,960 828,800
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,900 28,100 -6.33 28.89 -54,900 811,944
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,900 28,100 -6.33 28.90 -54,903 811,986
2016-06-01 2016-05-31 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -19,720 25,000 -44.10
2016-06-01 2016-05-31 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -19,720 74,567 -20.91 30.05 -592,566 2,240,664
2016-06-01 2016-05-31 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 19,720 94,287 26.45 0.38 7,592 36,300
2016-06-01 2016-05-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -5,280 44,720 -10.56
2016-06-01 2016-05-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -5,280 74,567 -6.61 30.06 -158,693 2,241,148
2016-06-01 2016-05-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 5,280 79,847 7.08 0.38 2,033 30,741
2016-02-02 2016-01-29 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 50,000 50,000
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -25,000 50,000 -33.33
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -7,709 73,718 -9.47 31.86 -245,573 2,348,309
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -17,291 81,427 -17.52 31.19 -539,379 2,540,050
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 25,000 98,718 33.91 0.38 9,625 38,006
2015-10-05 2015-10-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -560 72,919 -0.76 32.81 -18,373 2,392,341
2015-10-05 2015-10-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -6,940 73,479 -8.63 32.22 -223,630 2,367,736
2015-09-28 2015-09-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -12,764 7,690 -62.40
2015-09-28 2015-09-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 12,764 80,419 18.87 1.26 16,146 101,730
2015-07-06 2015-07-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 67,655 -9.98 51.10 -383,219 3,456,893
2015-06-08 2015-06-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -25,000 75,000 -25.00
2015-06-08 2015-06-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -25,000 75,155 -24.96 44.27 -1,106,852 3,327,420
2015-06-08 2015-06-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 25,000 100,155 33.26 0.38 9,625 38,560
2015-04-03 2015-04-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 74,359 -9.16 27.41 -205,552 2,037,957
2015-01-28 2015-01-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,300 81,859 -2.73 28.52 -65,602 2,334,840
2015-01-28 2015-01-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 35,000 35,000
2015-01-28 2015-01-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -5,200 84,159 -5.82 28.03 -145,732 2,358,590
2014-11-24 2014-11-20 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -30,000 88,484 -25.32 15.63 -469,011 1,383,332
2014-07-10 2014-07-08 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
118,484
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
30,000
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
30,000
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
30,000
2014-05-09 2014-05-07 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 9,090 9,090
2014-05-07 3 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
416,968
2014-05-07 3 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
416,968
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)